$ICUI
ICU Medical Inc Stock $icui

$icui Overview Financials Valuation SEC Filings Company Website

2019 Q1 Form 10-Q Financial Statement

#000088398419000017 Filed on May 10, 2019

Income Statement

Concept	2019 Q1	2018 Q1
Revenue	$330.9M	$372.0M
YoY Change	-11.05%	50.17%
Cost Of Revenue	$195.6M	$223.0M
YoY Change	-12.29%	40.45%
Gross Profit	$135.3M	$149.0M
YoY Change	-9.19%	67.52%
Gross Profit Margin	40.89%	40.05%
Selling, General & Admin	$72.63M	$85.02M
YoY Change	-14.56%	31.02%
% of Gross Profit	53.68%	57.06%
Research & Development	$12.82M	$12.59M
YoY Change	1.88%	8.12%
% of Gross Profit	9.48%	8.45%
Depreciation & Amortization	$19.07M	$18.30M
YoY Change	4.21%	57.87%
% of Gross Profit	14.1%	12.28%
Operating Expenses	$104.9M	$144.1M
YoY Change	-27.18%	36.02%
Operating Profit	$30.37M	$4.914M
YoY Change	518.07%	-128.93%
Interest Expense	$133.0K	$135.0K
YoY Change	-1.48%	-73.68%
% of Operating Profit	0.44%	2.75%
Other Income/Expense, Net	$3.191M	-$956.0K
YoY Change	-433.79%	-993.46%
Pretax Income	$33.43M	$3.823M
YoY Change	774.44%	-91.66%
Income Tax	$2.432M	-$1.052M
% Of Pretax Income	7.27%	-27.52%
Net Earnings	$31.00M	$4.875M
YoY Change	535.86%	-91.27%
Net Earnings / Revenue	9.37%	1.31%
Basic Earnings Per Share	$1.51	$0.24
Diluted Earnings Per Share	$1.44	$0.23
COMMON SHARES
Basic Shares Outstanding	20.53M shares	20.26M shares
Diluted Shares Outstanding	21.55M shares	21.40M shares

Balance Sheet

Concept	2019 Q1	2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$313.3M	$333.0M
YoY Change	-5.93%	64.93%
Cash & Equivalents	$296.0M	$318.8M
Short-Term Investments	$17.21M	$14.18M
Other Short-Term Assets	$2.516M	$6.483M
YoY Change	-61.19%	73.95%
Inventory	$321.7M	$295.5M
Prepaid Expenses
Receivables	$238.1M	$123.5M
Other Receivables	$22.70M	$153.9M
Total Short-Term Assets	$920.5M	$868.5M
YoY Change	5.98%	-2.03%
LONG-TERM ASSETS
Property, Plant & Equipment	$432.9M	$407.6M
YoY Change	6.22%	7.9%
Goodwill	$11.24M	$12.31M
YoY Change	-8.71%	87.06%
Intangibles	$131.1M	$136.6M
YoY Change	-4.09%	-14.13%
Long-Term Investments	$2.000M	$9.900M
YoY Change	-79.8%
Other Assets	$43.75M	$37.70M
YoY Change	16.04%	18.47%
Total Long-Term Assets	$692.8M	$624.2M
YoY Change	10.98%	6.43%
TOTAL ASSETS
Total Short-Term Assets	$920.5M	$868.5M
Total Long-Term Assets	$692.8M	$624.2M
Total Assets	$1.613B	$1.493B
YoY Change	8.07%	1.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$133.5M	$82.20M
YoY Change	62.47%	119.61%
Accrued Expenses	$104.9M	$116.4M
YoY Change	-9.95%	-4.27%
Deferred Revenue	$6.079M	$1.849M
YoY Change	228.77%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$238.4M	$198.6M
YoY Change	20.02%	23.63%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Other Long-Term Liabilities	$91.40M	$62.70M
YoY Change	45.77%	-29.87%
Total Long-Term Liabilities	$91.40M	$62.70M
YoY Change	45.77%	-61.86%
TOTAL LIABILITIES
Total Short-Term Liabilities	$238.4M	$198.6M
Total Long-Term Liabilities	$91.40M	$62.70M
Total Liabilities	$330.6M	$262.8M
YoY Change	25.8%	-20.65%
SHAREHOLDERS EQUITY
Retained Earnings	$651.7M	$596.8M
YoY Change	9.2%	4.19%
Common Stock	$661.9M	$634.0M
YoY Change	4.39%	7.8%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$13.06M	$3.176M
YoY Change	311.08%
Treasury Stock Shares	56.38K shares	13.24K shares
Shareholders Equity	$1.283B	$1.230B
YoY Change
Total Liabilities & Shareholders Equity	$1.613B	$1.493B
YoY Change	8.07%	1.34%

Cashflow Statement

Concept	2019 Q1	2018 Q1
OPERATING ACTIVITIES
Net Income	$31.00M	$4.875M
YoY Change	535.86%	-91.27%
Depreciation, Depletion And Amortization	$19.07M	$18.30M
YoY Change	4.21%	57.87%
Cash From Operating Activities	-$21.01M	-$20.73M
YoY Change	1.34%	-72.94%
INVESTING ACTIVITIES
Capital Expenditures	$28.67M	$26.54M
YoY Change	8.01%	61.89%
Acquisitions		$0.00
YoY Change		-100.0%
Other Investing Activities	$20.10M	$13.40M
YoY Change	50.0%	-108.53%
Cash From Investing Activities	-$10.51M	-$15.02M
YoY Change	-30.01%	-91.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$5.338M
YoY Change		43.57%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$17.23M	-$2.183M
YoY Change	689.37%	-133.08%
NET CHANGE
Cash From Operating Activities	-$21.01M	-$20.73M
Cash From Investing Activities	-$10.51M	-$15.02M
Cash From Financing Activities	-$17.23M	-$2.183M
Net Change In Cash	-$48.74M	-$37.94M
YoY Change	28.47%	-84.45%
FREE CASH FLOW
Cash From Operating Activities	-$21.01M	-$20.73M
Capital Expenditures	$28.67M	$26.54M
Free Cash Flow	-$49.68M	-$47.28M
YoY Change	5.09%	-49.17%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q1	dei	Amendment Flag AmendmentFlag	false
CY2019Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2019Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019Q1	dei	Document Period End Date DocumentPeriodEndDate	2019-03-31
CY2019Q1	dei	Document Type DocumentType	10-Q
CY2019Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000883984
CY2019Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20614407	shares
CY2019Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2019Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2019Q1	dei	Entity Registrant Name EntityRegistrantName	ICU MEDICAL INC/DE
CY2019Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2019Q1	dei	Trading Symbol TradingSymbol	icui
CY2018Q4	icui	Accrued Product Field Action. AccruedProductFieldAction.	5316000	USD
CY2019Q1	icui	Accrued Product Field Action. AccruedProductFieldAction.	4259000	USD
CY2018Q4	icui	Accrued Salaries And Benefits AccruedSalariesAndBenefits	20538000	USD
CY2019Q1	icui	Accrued Salaries And Benefits AccruedSalariesAndBenefits	29259000	USD
CY2018Q4	icui	Accruedfreight Accruedfreight	10953000	USD
CY2019Q1	icui	Accruedfreight Accruedfreight	10795000	USD
CY2018Q4	icui	Accruedlegalfees Accruedlegalfees	1400000	USD
CY2019Q1	icui	Accruedlegalfees Accruedlegalfees	1261000	USD
CY2018Q4	icui	Accruedothertaxes Accruedothertaxes	3213000	USD
CY2019Q1	icui	Accruedothertaxes Accruedothertaxes	414000	USD
CY2018	icui	Accruedresearchanddevelopmentexpense Accruedresearchanddevelopmentexpense	1451000	USD
CY2019Q1	icui	Accruedresearchanddevelopmentexpense Accruedresearchanddevelopmentexpense	0	USD
CY2019Q1	icui	Businesscombinationconsiderationsubsequenttransfer Businesscombinationconsiderationsubsequenttransfer	8000000	USD
CY2018Q4	icui	Consignedinventory Consignedinventory	1118000	USD
CY2019Q1	icui	Consignedinventory Consignedinventory	1118000	USD
CY2018Q1	icui	Contingentconsiderationgross Contingentconsiderationgross	225000000	USD
CY2018Q4	icui	Contractsettlement Contractsettlement	1667000	USD
CY2019Q1	icui	Contractsettlement Contractsettlement	1250000	USD
CY2018Q1	icui	Contractsettlement St ContractsettlementST	-28900000	USD
CY2018Q4	icui	Contractsettlement St ContractsettlementST	-12700000	USD
CY2018	icui	Contractsettlement St ContractsettlementST	2083000	USD
CY2019Q1	icui	Contractsettlement St ContractsettlementST	1667000	USD
CY2018Q1	icui	Contractsettlementtaxbenefit Contractsettlementtaxbenefit	5700000	USD
CY2018Q4	icui	Deferredtaxcharge Deferredtaxcharge	1180000	USD
CY2019Q1	icui	Deferredtaxcharge Deferredtaxcharge	1180000	USD
CY2019Q1	icui	Discretetaxbenefitcontingentconsiderationrevaluation Discretetaxbenefitcontingentconsiderationrevaluation	1800000	USD
CY2018Q1	icui	Increase Decreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes	-3272000	USD
CY2019Q1	icui	Increase Decreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes	-1068000	USD
CY2018Q1	icui	Legalsettlementcharge Legalsettlementcharge	28917000	USD
CY2019Q1	icui	Legalsettlementcharge Legalsettlementcharge	2783000	USD
CY2018Q4	icui	Liabilitiesforcontracts Liabilitiesforcontracts	14020000	USD
CY2019Q1	icui	Liabilitiesforcontracts Liabilitiesforcontracts	11591000	USD
CY2019Q1	icui	Optiontoextendinyears Optiontoextendinyears	P5Y0M
CY2018Q4	icui	Outsidesalescommissions Outsidesalescommissions	3977000	USD
CY2019Q1	icui	Outsidesalescommissions Outsidesalescommissions	4040000	USD
CY2018Q4	icui	Prepaidinsuranceandpropertytaxes Prepaidinsuranceandpropertytaxes	2666000	USD
CY2019Q1	icui	Prepaidinsuranceandpropertytaxes Prepaidinsuranceandpropertytaxes	3070000	USD
CY2018Q4	icui	Prepaidothertaxes Prepaidothertaxes	5072000	USD
CY2019Q1	icui	Prepaidothertaxes Prepaidothertaxes	5207000	USD
CY2018Q1	icui	Provision For Warranty And Returns ProvisionForWarrantyAndReturns	367000	USD
CY2019Q1	icui	Provision For Warranty And Returns ProvisionForWarrantyAndReturns	2692000	USD
CY2018Q1	icui	Restructuringandstrategictransaction Restructuringandstrategictransaction	21569000	USD
CY2019Q1	icui	Restructuringandstrategictransaction Restructuringandstrategictransaction	24392000	USD
CY2018Q1	icui	Strategictransactionexpenses Strategictransactionexpenses	-19800000	USD
CY2019Q1	icui	Strategictransactionexpenses Strategictransactionexpenses	-23600000	USD
CY2018	icui	Thirdparty Inventory ThirdpartyInventory	1089000	USD
CY2019Q1	icui	Thirdparty Inventory ThirdpartyInventory	30000	USD
CY2019Q1	icui	Treasury Stock Purchase Plan TreasuryStockPurchasePlan	40000000	USD
CY2019Q1	invest	Investment Contract Settlement Date Range End InvestmentContractSettlementDateRangeEnd	2020-07-22
CY2019Q1	invest	Investment Contract Settlement Date Range Start InvestmentContractSettlementDateRangeStart	2019-01-15
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	120469000	USD
CY2019Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	133542000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	176298000	USD
CY2019Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	238069000	USD
CY2018Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	42913000	USD
CY2019Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	10656000	USD
CY2018Q4	us-gaap	Accrued Employee Benefits Current And Noncurrent AccruedEmployeeBenefitsCurrentAndNoncurrent	962000	USD
CY2019Q1	us-gaap	Accrued Employee Benefits Current And Noncurrent AccruedEmployeeBenefitsCurrentAndNoncurrent	990000	USD
CY2018Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	3734000	USD
CY2019Q1	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	3734000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	128820000	USD
CY2019Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	104865000	USD
CY2018Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	15996000	USD
CY2019Q1	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	12712000	USD
CY2018Q4	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	1779000	USD
CY2019Q1	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	1763000	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	262223000	USD
CY2019Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	277001000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-14959000	USD
CY2018Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2254000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-16945000	USD
CY2019Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-17881000	USD
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	657899000	USD
CY2019Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	659819000	USD
CY2018Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	5338000	USD
CY2019Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	18157000	USD
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5462000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6209000	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5768000	USD
CY2019Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	7852000	USD
CY2018Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	72000	USD
CY2019Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	72000	USD
CY2018Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4100000	USD
CY2019Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4000000	USD
CY2018Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	24781	shares
CY2019Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9998	shares
CY2018Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	269000	USD
CY2019Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2018Q4	us-gaap	Assets Assets	1585391000	USD
CY2019Q1	us-gaap	Assets Assets	1613271000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	927036000	USD
CY2019Q1	us-gaap	Assets Current AssetsCurrent	920507000	USD
CY2019Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	20822000	USD
CY2018Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	39354000	USD
CY2019Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	19235000	USD
CY2018Q1	us-gaap	Available For Sale Debt Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesGrossUnrealizedLoss	0	USD
CY2019Q1	us-gaap	Available For Sale Debt Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesGrossUnrealizedLoss	0	USD
CY2018Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	40086000	USD
CY2018Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	37329000	USD
CY2019Q1	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	17214000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	2025000	USD
CY2019Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	2021000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	37329000	USD
CY2019Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	17214000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	39354000	USD
CY2019Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	19235000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	37329000	USD
CY2019Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	17214000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	2025000	USD
CY2019Q1	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	2021000	USD
CY2018Q4	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	2025000	USD
CY2019Q1	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	2021000	USD
CY2018Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-4000000	USD
CY2019Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-7700000	USD
CY2018Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	280000	USD
CY2019Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	13131000	USD
CY2018Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	0	USD
CY2019Q1	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	30641000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	290072000	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	254536000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	344781000	USD
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	296044000	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-35536000	USD
CY2019Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-48737000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	382110000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	313258000	USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2019Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2019Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2019Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20492000	shares
CY2019Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20668000	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20491000	shares
CY2019Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20612000	shares
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	2049000	USD
CY2019Q1	us-gaap	Common Stock Value CommonStockValue	2067000	USD
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	22088000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	30062000	USD
CY2018Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	70864000	USD
CY2019Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	73182000	USD
CY2017Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	7066000	USD
CY2018Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	11761000	USD
CY2018Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4282000	USD
CY2019Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	6425000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3814000	USD
CY2019Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	6079000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	468000	USD
CY2019Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	346000	USD
CY2018Q4	us-gaap	Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue	0	USD
CY2019Q1	us-gaap	Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue	0	USD
CY2018Q1	us-gaap	Cost Of Revenue CostOfRevenue	223032000	USD
CY2019Q1	us-gaap	Cost Of Revenue CostOfRevenue	195629000	USD
CY2017Q4	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	6330000	USD
CY2018Q4	us-gaap	Deferred Costs And Other Assets DeferredCostsAndOtherAssets	1951000	USD
CY2019Q1	us-gaap	Deferred Costs And Other Assets DeferredCostsAndOtherAssets	3655000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	38654000	USD
CY2019Q1	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	33396000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	721000	USD
CY2019Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	726000	USD
CY2019Q1	us-gaap	Foreign Currency Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months	900000	USD
CY2018Q4	us-gaap	Deposit Assets DepositAssets	1087000	USD
CY2019Q1	us-gaap	Deposit Assets DepositAssets	1232000	USD
CY2018Q1	us-gaap	Depreciation Depreciation	14200000	USD
CY2019Q1	us-gaap	Depreciation Depreciation	15100000	USD
CY2018Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	18304000	USD
CY2019Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	19074000	USD
CY2018Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	235000	USD
CY2019Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	155000	USD
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.24
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.51
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.23
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.44
CY2018Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	2400000	USD
CY2019Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	18000	USD
CY2018Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.28
CY2019Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.07
CY2018Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2019Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2018Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	3400000	USD
CY2019Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	5600000	USD
CY2019Q1	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	7700000	USD
CY2018Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	47400000	USD
CY2019Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	39700000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	48186000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	52186000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	41343000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	17048000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	15624000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	15773000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	15897000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	16099000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	173372000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	173970000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	125186000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	121784000	USD
CY2018Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	7409000	USD
CY2019Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	7410000	USD
CY2019Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	USD
CY2018Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-53000	USD
CY2019Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-12682000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	11195000	USD
CY2019Q1	us-gaap	Goodwill Goodwill	11241000	USD
CY2019Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	46000	USD
CY2018Q1	us-gaap	Gross Profit GrossProfit	149001000	USD
CY2019Q1	us-gaap	Gross Profit GrossProfit	135303000	USD
CY2018Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	5000000	USD
CY2019Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	3823000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	33430000	USD
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1052000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2432000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	8737000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3075000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	11901000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	49534000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	32779000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	0	USD
CY2018Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-29455000	USD
CY2019Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-34814000	USD
CY2018Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-10942000	USD
CY2019Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	11968000	USD
CY2018Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2348000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	7542000	USD
CY2018Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3569000	USD
CY2019Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-10319000	USD
CY2018Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1145000	shares
CY2019Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1024000	shares
CY2018Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	8235000	USD
CY2019Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	9269000	USD
CY2018Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	181607000	USD
CY2019Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	183239000	USD
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	133421000	USD
CY2019Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	131053000	USD
CY2018Q1	us-gaap	Interest Expense InterestExpense	135000	USD
CY2019Q1	us-gaap	Interest Expense InterestExpense	133000	USD
CY2018Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	154150000	USD
CY2019Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	163308000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	311163000	USD
CY2019Q1	us-gaap	Inventory Net InventoryNet	321747000	USD
CY2018Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	104104000	USD
CY2019Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	101102000	USD
CY2018Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	52909000	USD
CY2019Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	57337000	USD
CY2018Q1	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	142000	USD
CY2019Q1	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	28000	USD
CY2019Q1	us-gaap	Lease Cost LeaseCost	2526000	USD
CY2018Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	48151000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	46262000	USD
CY2018Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	13235000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	13390000	USD
CY2018Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	8326000	USD
CY2018Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	5615000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	5795000	USD
CY2018Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	5914000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	5955000	USD
CY2018Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	6489000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	6391000	USD
CY2018Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	8572000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	8713000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	6018000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	7656000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1585391000	USD
CY2019Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1613271000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	249289000	USD
CY2019Q1	us-gaap	Liabilities Current LiabilitiesCurrent	238407000	USD
CY2018Q4	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	20592000	USD
CY2019Q1	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	48010000	USD
CY2019Q1	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2022-11-08
CY2019Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	150000000	USD
CY2019Q1	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	150000000	USD
CY2018Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	203431000	USD
CY2019Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	207665000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2183000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-17232000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15021000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10513000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-20732000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21010000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	4875000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	30998000	USD
CY2019Q1	us-gaap	New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption Quantification NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification	40400000	USD
CY2018Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-956000	USD
CY2019Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3191000	USD
CY2018Q1	us-gaap	Operating Expenses OperatingExpenses	144087000	USD
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	104931000	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	4914000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	30372000	USD
CY2019Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	2430000	USD
CY2019Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	38606000	USD
CY2018Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	USD
CY2019Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7966000	USD
CY2019Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	30640000	USD
CY2019Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	2219000	USD
CY2018Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	USD
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	38365000	USD
CY2019Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0557
CY2019Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y0M
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	9848000	USD
CY2019Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	10006000	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	1696000	USD
CY2019Q1	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	1429000	USD
CY2018Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1548000	USD
CY2019Q1	us-gaap	Other Assets Current OtherAssetsCurrent	2516000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	40419000	USD
CY2019Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	43750000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	-2000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	-6000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	17213000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-936000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	17392000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-818000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	1814000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	650000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax	573000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax	205000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	15397000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1592000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	17213000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-936000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	0	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	0	USD
CY2018Q1	us-gaap	Other Noncash Expense OtherNoncashExpense	4783000	USD
CY2019Q1	us-gaap	Other Noncash Expense OtherNoncashExpense	4371000	USD
CY2018Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	12476000	USD
CY2019Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	13050000	USD
CY2018Q4	us-gaap	Other Receivables OtherReceivables	20137000	USD
CY2019Q1	us-gaap	Other Receivables OtherReceivables	0	USD
CY2019Q1	us-gaap	Payments For Restructuring PaymentsForRestructuring	767000	USD
CY2018Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	5338000	USD
CY2019Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	18157000	USD
CY2019Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	18200000	USD
CY2018Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1899000	USD
CY2019Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1949000	USD
CY2018Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	4478000	USD
CY2019Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	4409000	USD
CY2018Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	26544000	USD
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	28671000	USD
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2019Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2019Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	46117000	USD
CY2019Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	29910000	USD
CY2018Q4	us-gaap	Prepaid Taxes PrepaidTaxes	11348000	USD
CY2019Q1	us-gaap	Prepaid Taxes PrepaidTaxes	17523000	USD
CY2018Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	4900000	USD
CY2019Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	24500000	USD
CY2018Q1	us-gaap	Proceeds From Sale Of Other Productive Assets ProceedsFromSaleOfOtherProductiveAssets	13000000	USD
CY2019Q1	us-gaap	Proceeds From Sale Of Other Productive Assets ProceedsFromSaleOfOtherProductiveAssets	0	USD
CY2018Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2019Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	16000	USD
CY2018Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3155000	USD
CY2019Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	925000	USD
CY2018Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1124000	USD
CY2019Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	904000	USD
CY2018Q1	us-gaap	Profit Loss ProfitLoss	4875000	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	30998000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	694864000	USD
CY2019Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	709939000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	432641000	USD
CY2019Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	432938000	USD
CY2018Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	448000	USD
CY2019Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2096000	USD
CY2018Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-179000	USD
CY2019Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-118000	USD
CY2018Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12586000	USD
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12823000	USD
CY2019Q1	us-gaap	Restructuring And Related Cost Cost Incurred To Date1 RestructuringAndRelatedCostCostIncurredToDate1	23900000	USD
CY2019Q1	us-gaap	Restructuring Charges RestructuringCharges	756000	USD
CY2018Q4	us-gaap	Restructuring Reserve RestructuringReserve	1416000	USD
CY2019Q1	us-gaap	Restructuring Reserve RestructuringReserve	1405000	USD
CY2019Q1	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	0	USD
CY2018Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	1046000	USD
CY2019Q1	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	1132000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	620747000	USD
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	651745000	USD
CY2018Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	372033000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	330932000	USD
CY2018Q1	us-gaap	Revenues Revenues	372033000	USD
CY2019Q1	us-gaap	Revenues Revenues	330932000	USD
CY2019Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	98000	USD
CY2018Q4	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	2941000	USD
CY2019Q1	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	2567000	USD
CY2018Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	85015000	USD
CY2019Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	72633000	USD
CY2018Q1	us-gaap	Share Based Compensation ShareBasedCompensation	5462000	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	6209000	USD
CY2019Q1	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	77642	shares
CY2019Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	96000	USD
CY2018Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3155000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	925000	USD
CY2019Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	7200000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	1198254000	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	1229951000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	1263655000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	1282694000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1263655000	USD
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1282694000	USD
CY2018Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	408	shares
CY2019Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	56379	shares
CY2018Q4	us-gaap	Treasury Stock Value TreasuryStockValue	95000	USD
CY2019Q1	us-gaap	Treasury Stock Value TreasuryStockValue	13056000	USD
CY2018Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21400000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21551000	shares
CY2018Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20255000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20527000	shares
CY2019Q1	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recently Issued Accounting Standards</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">I</font><font style="font-family:inherit;font-size:10pt;">n August 2018, the FASB issued ASU No. 2018-15, Intangibles-Goodwill and Other-Internal-Use Software (Topic 350): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract. The amendments in this update align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software and hosting arrangements that include an internal use software license. Costs to develop or obtain internal-use software that cannot be capitalized under subtopic 350-40, such as training costs and certain data conversion costs, also cannot be capitalized for a hosting arrangement that is a service contract. Therefore, an entity in a hosting arrangement that is a service contract determines which project stage (that is, preliminary project stage, application development stage, or post-implementation stage) an implementation activity relates to. Costs for implementation activities in the application development stage are capitalized depending on the nature of the costs, while costs incurred during the preliminary project and post-implementation stages are expensed as the activities are performed. The amendments in this update require the entity to expense the capitalized implementation costs of a hosting arrangement that is a service contract over the term of the hosting arrangement. The amendments in this update are effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. The amendments in this update should be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. We are currently evaluating the impact of this ASU on the consolidated financial statements and related disclosures. </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">    </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font><font style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. The amendments in this update modify the disclosure requirements in Topic 820. The amendments remove from disclosure: the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy; the policy for timing of transfers between levels; and the valuation processes for Level 3 fair value measurements. The amendments also made the following disclosure modifications: for investments in certain entities that calculate net asset value, an entity is required to disclose the timing of liquidation of an investee’s assets and the date when restrictions from redemption might lapse only if the investee has communicated the timing to the entity or announced the timing publicly; and the amendments clarify that the measurement uncertainty disclosure is to communicate information about the uncertainty in measurement as of the reporting date. The amendments also added the following disclosure requirements: the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period; and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. For certain unobservable inputs, an entity may disclose other quantitative information (such as the median or arithmetic average) in lieu of the weighted average if the entity determines that other quantitative information would be a more reasonable and rational method to reflect the distribution of unobservable inputs used to develop Level 3 fair value measurements. The amendments in ASU 2018-02 are effective for fiscal years beginning after December 15, 2019. Early adoption is permitted. We are currently evaluating the impact of this ASU on the consolidated financial statements and related disclosures.    </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2017, the FASB issued ASU No. 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The amendments in this update remove the second step of the impairment test. An entity will apply a one-step quantitative test and record the amount of goodwill impairment as the excess of a reporting unit's carrying amount over its fair value, not to exceed the total amount of goodwill allocated to the reporting unit. The new guidance does not amend the optional qualitative assessment of goodwill impairment. The amendments in ASU 2017-04 are effective for the annual or interim impairment test in fiscal years beginning after December 15, 2019. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. This ASU is not expected to have a material impact on our consolidated financial statements or related footnote disclosures.</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">    </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. This update amends the FASB's guidance on the impairment of financial instruments by requiring timelier recording of credit losses on loans and other financial instruments. The ASU adds an impairment model that is based on expected losses rather than incurred losses. The ASU also amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. The amendments in this update will be effective for fiscal years beginning after December 15, 2019. Early adoption is permitted as of the fiscal years beginning after December 15, 2018. The updated guidance requires a modified retrospective adoption. We are currently evaluating the impact of this ASU on the consolidated financial statements and related disclosures.</font></div></div>

Files In Submission

Name	View Source	Status
0000883984-19-000017-index-headers.html	Edgar Link	pending
0000883984-19-000017-index.html	Edgar Link	pending
0000883984-19-000017.txt	Edgar Link	pending
0000883984-19-000017-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
icui-20190331.xml	Edgar Link	completed
icui-20190331.xsd	Edgar Link	pending
icui-20190331_cal.xml	Edgar Link	unprocessable
icui-20190331_def.xml	Edgar Link	unprocessable
icui-20190331_lab.xml	Edgar Link	unprocessable
icui-20190331_pre.xml	Edgar Link	unprocessable
icui-ex101.htm	Edgar Link	pending
icui-ex311.htm	Edgar Link	pending
icui-ex312.htm	Edgar Link	pending
icui-ex321.htm	Edgar Link	pending
icui0331201910-q.htm	Edgar Link	pending
icumedicalinc.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ICUI
ICU Medical Inc Stock $icui

2019 Q1 Form 10-Q Financial Statement

#000088398419000017 Filed on May 10, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICUI ICU Medical Inc Stock $icui

2019 Q1 Form 10-Q Financial Statement

#000088398419000017 Filed on May 10, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICUI
ICU Medical Inc Stock $icui